Charles Schwab’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $99.3M | Buy |
789,715
+13,942
| +2% | +$1.75M | 0.02% | 683 |
|
|
2025
Q1 | $85.8M | Buy |
775,773
+13,216
| +2% | +$1.46M | 0.02% | 727 |
|
|
2024
Q4 | $104M | Buy |
762,557
+15,266
| +2% | +$2.08M | 0.02% | 646 |
|
|
2024
Q3 | $86.1M | Sell |
747,291
-5,210
| -0.7% | -$600K | 0.02% | 754 |
|
|
2024
Q2 | $104M | Buy |
752,501
+27,323
| +4% | +$3.76M | 0.02% | 633 |
|
|
2024
Q1 | $100M | Buy |
725,178
+38,343
| +6% | +$5.29M | 0.02% | 603 |
|
|
2023
Q4 | $90.5M | Buy |
686,835
+63,568
| +10% | +$8.38M | 0.02% | 608 |
|
|
2023
Q3 | $70.1M | Buy |
623,267
+18,334
| +3% | +$2.06M | 0.02% | 684 |
|
|
2023
Q2 | $57M | Buy |
604,933
+20,541
| +4% | +$1.94M | 0.02% | 785 |
|
|
2023
Q1 | $59.2M | Buy |
584,392
+18,353
| +3% | +$1.86M | 0.02% | 724 |
|
|
2022
Q4 | $67.6M | Buy |
566,039
+25,063
| +5% | +$2.99M | 0.02% | 635 |
|
|
2022
Q3 | $57.5M | Buy |
540,976
+7,975
| +1% | +$847K | 0.02% | 677 |
|
|
2022
Q2 | $52M | Buy |
533,001
+12,152
| +2% | +$1.18M | 0.02% | 730 |
|
|
2022
Q1 | $48.8M | Buy |
520,849
+11,234
| +2% | +$1.05M | 0.01% | 885 |
|
|
2021
Q4 | $43.4M | Buy |
509,615
+12,547
| +3% | +$1.07M | 0.01% | 996 |
|
|
2021
Q3 | $47.7M | Buy |
497,068
+17,419
| +4% | +$1.67M | 0.02% | 906 |
|
|
2021
Q2 | $46.7M | Buy |
479,649
+12,579
| +3% | +$1.22M | 0.02% | 923 |
|
|
2021
Q1 | $45.4M | Sell |
467,070
-7,451
| -2% | -$725K | 0.02% | 904 |
|
|
2020
Q4 | $45.5M | Buy |
474,521
+3,989
| +0.8% | +$382K | 0.02% | 824 |
|
|
2020
Q3 | $45.2M | Buy |
470,532
+8,050
| +2% | +$774K | 0.02% | 708 |
|
|
2020
Q2 | $56.4M | Buy |
462,482
+10,453
| +2% | +$1.28M | 0.03% | 572 |
|
|
2020
Q1 | $39.1M | Buy |
452,029
+10,552
| +2% | +$913K | 0.02% | 622 |
|
|
2019
Q4 | $47.5M | Buy |
441,477
+8,420
| +2% | +$905K | 0.03% | 663 |
|
|
2019
Q3 | $39M | Buy |
433,057
+31,520
| +8% | +$2.84M | 0.02% | 723 |
|
|
2019
Q2 | $33.9M | Buy |
401,537
+15,588
| +4% | +$1.32M | 0.02% | 794 |
|
|
2019
Q1 | $34M | Buy |
385,949
+26,503
| +7% | +$2.33M | 0.02% | 770 |
|
|
2018
Q4 | $25.7M | Buy |
359,446
+14,216
| +4% | +$1.02M | 0.02% | 828 |
|
|
2018
Q3 | $42.4M | Sell |
345,230
-127,057
| -27% | -$15.6M | 0.03% | 614 |
|
|
2018
Q2 | $46.4M | Buy |
472,287
+32,769
| +7% | +$3.22M | 0.03% | 540 |
|
|
2018
Q1 | $36.5M | Buy |
439,518
+29,996
| +7% | +$2.49M | 0.03% | 627 |
|
|
2017
Q4 | $31.8M | Buy |
409,522
+25,834
| +7% | +$2M | 0.03% | 663 |
|
|
2017
Q3 | $23.5M | Buy |
383,688
+22,441
| +6% | +$1.38M | 0.02% | 803 |
|
|
2017
Q2 | $16.6M | Buy |
361,247
+14,341
| +4% | +$660K | 0.02% | 996 |
|
|
2017
Q1 | $15M | Buy |
346,906
+27,245
| +9% | +$1.18M | 0.02% | 1019 |
|
|
2016
Q4 | $12.4M | Buy |
319,661
+23,540
| +8% | +$911K | 0.01% | 1099 |
|
|
2016
Q3 | $15M | Buy |
296,121
+41,545
| +16% | +$2.1M | 0.02% | 880 |
|
|
2016
Q2 | $11.6M | Sell |
254,576
-141,394
| -36% | -$6.43M | 0.01% | 979 |
|
|
2016
Q1 | $15.7M | Buy |
395,970
+63,804
| +19% | +$2.52M | 0.02% | 758 |
|
|
2015
Q4 | $18.8M | Buy |
332,166
+16,312
| +5% | +$923K | 0.03% | 627 |
|
|
2015
Q3 | $12.6M | Buy |
315,854
+68,109
| +27% | +$2.71M | 0.02% | 834 |
|
|
2015
Q2 | $11.8M | Buy |
247,745
+7,508
| +3% | +$359K | 0.02% | 901 |
|
|
2015
Q1 | $9.54M | Buy |
240,237
+29,098
| +14% | +$1.16M | 0.01% | 1025 |
|
|
2014
Q4 | $4.72M | Buy |
211,139
+6,946
| +3% | +$155K | 0.01% | 1493 |
|
|
2014
Q3 | $3.2M | Buy |
204,193
+4,174
| +2% | +$65.4K | 0.01% | 1691 |
|
|
2014
Q2 | $2.97M | Buy |
200,019
+12,388
| +7% | +$184K | 0.01% | 1745 |
|
|
2014
Q1 | $3.02M | Buy |
187,631
+4,892
| +3% | +$78.8K | 0.01% | 1707 |
|
|
2013
Q4 | $1.71M | Buy |
182,739
+17,148
| +10% | +$160K | ﹤0.01% | 2010 |
|
|
2013
Q3 | $1.92M | Buy |
165,591
+7,574
| +5% | +$87.8K | ﹤0.01% | 1863 |
|
|
2013
Q2 | $2.15M | Buy |
+158,017
| New | +$2.15M | ﹤0.01% | 1715 |
|